12+ hour, 48+ min ago  (373+ words) Genetic variants could impact how well GLP-1 receptor agonists work for some patients, new study finds. Apr. 11, 2026 at 4: 32am Knowing ahead of time who is likely to respond to GLP-1 receptor agonists would help patients get on the right drugs faster,…...

3+ hour, 7+ min ago  (586+ words) Kevin MD. com Is science shaping the future of obesity care, or is pharmaceutical marketing now in the driver's seat? After 15 years in bariatric surgery, I am witnessing a shift that should make us all pause. From the gold standard of…...

3+ hour, 55+ min ago  (137+ words) The Weight-Loss Pill Revolution: A Game-Changer or Just Another Quick Fix? Apr. 11, 2026 at 1: 12pm A pharmaceutical company that developed the weight-loss pill Foundayo. The FDA's expedited review of Foundayo raises concerns about the long-term safety and efficacy of the drug, as…...

4+ hour, 43+ min ago  (233+ words) A 35-year-old mother shares her journey from size 30 to size 6 despite the 'Ozempic plateau' affecting 85% of users. Apr. 11, 2026 at 12: 24pm Emilly Murray, a 35-year-old mother of three, shares her journey from a size 30 to a size 6, despite encountering the dreaded 'Ozempic…...

2+ hour, 44+ min ago  (1543+ words) Trending in 2026: Pink Gelatin Trick for weight loss. Discover Gelatine Sculpt's benefits, usage & why demand is rising fast. This report provides a structured overview of Gelatine Sculpt, including its formulation, intended benefits, usage approach, and overall positioning within the current…...

1+ hour, 36+ min ago  (1338+ words) Bioengineer. org In recent years, the role of micro RNAs (mi RNAs) in metabolic diseases has gained immense scientific interest. Among these small, non-coding RNAs, certain mi RNAs have emerged as critical regulators of lipid metabolism and inflammatory pathways, especially…...

14+ hour, 24+ min ago  (873+ words) April 10 (Reuters) " Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23 And Me. The study of nearly 28, 000 23 And Me users who reported taking the…...

10+ hour, 38+ min ago  (226+ words) Diabetes Management: When used thoughtfully and as part of a balanced diet, these 'kitchen heroes" could go a long way out to reduce insulin resistance, support long-term metabolic health and smooth out glucose spikes. Diabetes Management: For millions of individuals…...

2+ hour, 43+ min ago  (560+ words) Under trial, not approved: Inside the world of "Chinese peptides" for weight loss in India'The Times of India...

1+ day, 8+ hour ago  (390+ words) Sahm Novo Nordisk Leans Into Obesity Care With ORION Data And Wegovy Pricing Novo Nordisk A/S Sponsored ADR Class B - Novo Nordisk (NYSE: NVO) reported new ORION study results showing oral semaglutide produced greater weight loss and better tolerability…...